
SenzaGen Investor Relations Material
Latest events

Status Update
SenzaGen
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SenzaGen
Access all reports
SenzaGen is a Sweden-based biotechnology company specializing in non-animal test methods for assessing chemical safety. The company develops and markets in vitro assays for detecting skin sensitization and other toxicological endpoints. Its technology is used in industries including cosmetics, chemicals, and pharmaceuticals. SenzaGen is headquartered in Lund, Sweden, and its shares are listed on the NASDAQ First North Growth Market.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
SENZA
Country
🇸🇪 Sweden